BSE Live
Dec 03, 16:02Prev. Close
260.80
Open Price
260.80
Bid Price (Qty.)
254.50 (5)
Offer Price (Qty.)
265.00 (79)
NSE Live
Dec 03, 15:58Prev. Close
261.65
Open Price
261.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Indoco Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 18.45 | 18.44 | 18.43 | 18.43 | 18.43 | |
| Total Share Capital | 18.45 | 18.44 | 18.43 | 18.43 | 18.43 | |
| Reserves and Surplus | 1,003.55 | 1,091.46 | 1,009.82 | 886.21 | 750.56 | |
| Total Reserves and Surplus | 1,003.55 | 1,091.46 | 1,009.82 | 886.21 | 750.56 | |
| Total Shareholders Funds | 1,022.00 | 1,109.90 | 1,028.25 | 904.64 | 768.99 | |
| Minority Interest | -3.62 | 0.60 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 533.20 | 351.73 | 143.50 | 95.88 | 96.94 | |
| Deferred Tax Liabilities [Net] | 13.36 | 11.83 | 6.14 | 10.60 | 0.00 | |
| Other Long Term Liabilities | 21.17 | 24.66 | 22.40 | 18.37 | 14.44 | |
| Long Term Provisions | 35.82 | 33.68 | 33.40 | 31.74 | 27.77 | |
| Total Non-Current Liabilities | 603.54 | 421.90 | 205.44 | 156.60 | 139.15 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 444.83 | 303.42 | 171.00 | 148.32 | 116.32 | |
| Trade Payables | 208.13 | 153.64 | 123.46 | 133.29 | 113.23 | |
| Other Current Liabilities | 109.88 | 106.90 | 80.51 | 95.80 | 130.46 | |
| Short Term Provisions | 45.15 | 48.36 | 49.54 | 47.45 | 46.91 | |
| Total Current Liabilities | 807.99 | 612.33 | 424.51 | 424.85 | 406.92 | |
| Total Capital And Liabilities | 2,429.91 | 2,144.73 | 1,658.20 | 1,486.09 | 1,315.06 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 849.06 | 788.21 | 612.19 | 531.85 | 528.41 | |
| Intangible Assets | 126.30 | 144.55 | 65.97 | 23.16 | 41.53 | |
| Capital Work-In-Progress | 276.12 | 102.87 | 55.39 | 52.82 | 25.12 | |
| Fixed Assets | 1,295.90 | 1,057.58 | 791.76 | 676.54 | 638.04 | |
| Non-Current Investments | 1.46 | 1.46 | 1.46 | 0.02 | 0.02 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 19.36 | |
| Long Term Loans And Advances | 3.61 | 3.12 | 2.85 | 1.41 | 0.96 | |
| Other Non-Current Assets | 106.08 | 106.37 | 53.85 | 34.41 | 34.07 | |
| Total Non-Current Assets | 1,428.58 | 1,190.06 | 850.02 | 712.47 | 692.54 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 7.24 | 1.00 | 0.00 | 0.00 | |
| Inventories | 419.35 | 353.06 | 325.99 | 310.52 | 237.85 | |
| Trade Receivables | 352.41 | 406.20 | 350.94 | 297.24 | 233.82 | |
| Cash And Cash Equivalents | 17.07 | 24.32 | 13.35 | 19.77 | 14.34 | |
| Short Term Loans And Advances | 3.31 | 1.49 | 0.69 | 0.54 | 0.40 | |
| OtherCurrentAssets | 209.20 | 162.34 | 116.22 | 145.54 | 136.12 | |
| Total Current Assets | 1,001.34 | 954.67 | 808.18 | 773.62 | 622.53 | |
| Total Assets | 2,429.91 | 2,144.73 | 1,658.20 | 1,486.09 | 1,315.06 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 165.23 | 167.06 | 83.15 | 60.27 | 55.72 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 1.46 | 1.46 | 1.46 | 0.02 | 0.02 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 7.24 | 1.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher